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Summary
In an effort to prevent the formation of pathogenic bio-
ﬁlms on hydroxyapatite (HA)-based clinical devices
and surfaces, we present a study evaluating the
antimicrobial efﬁcacy of Spherical biogenic Se-
Nanostructures Embedded in Organic material (Bio
Se-NEMO-S) produced by Bacillus mycoides SelTE01
in comparison with two different chemical selenium
nanoparticle (SeNP) classes. These nanomaterials
have been studied as potential antimicrobials for
eradication of established HA-grown bioﬁlms, for pre-
venting bioﬁlm formation on HA-coated surfaces and
for inhibition of planktonic cell growth of Pseu-
domonas aeruginosa NCTC 12934 and Staphylococ-
cus aureus ATCC 25923. Bio Se-NEMO resulted more
efﬁcacious than those chemically produced in all
tested scenarios. Bio Se-NEMO produced by B. my-
coides SelTE01 after 6 or 24 h of Na2SeO3 exposure
show the same effective antibioﬁlm activity towards
both P. aeruginosa and S. aureus strains at
0.078 mg ml1 (Bio Se-NEMO6) and 0.3125 mg ml
1
(Bio Se-NEMO24). Meanwhile, chemically synthesized
SeNPs at the highest tested concentration
(2.5 mg ml1) have moderate antimicrobial activity.
The confocal laser scanning micrographs demon-
strate that the majority of the P. aeruginosa and S. au-
reus cells exposed to biogenic SeNPs within the
bioﬁlm are killed or eradicated. Bio Se-NEMO there-
fore displayed good antimicrobial activity towards
HA-grown bioﬁlms and planktonic cells, becoming
possible candidates as new antimicrobials.
Introduction
In the last 20 years, the potential to use nanoparticles
(NPs) as antimicrobial agents has been evaluated
(Ankamwar et al., 2005). Primarily, the focus was to syn-
thesize NPs using various chemical methods. However,
both the high cost of production and presence of toxic
by-products generated a demand for novel methods to
synthesize NPs (Ankamwar et al., 2005). Biological sys-
tems such as plants, fungi and bacteria have the capac-
ity to convert several toxic metal ions into less toxic
forms including metal precipitants or NPs (Suresh et al.,
2004; Bhainsa and D’Souza, 2006; Song et al., 2009).
Thanks to the potential technological importance of such
NPs, research interest has been focused on the use of
these organisms to produce NPs with eco-friendly and
‘green synthesis’ methods (Ingale and Chaudhari, 2013).
One of the ﬁrst classes of biogenic NPs to be evaluated
was silver NPs (AgNPs), due to the demonstrated
antimicrobial ability of metallic silver (Ag; Dos Santos
et al., 2014). Generally, biogenic AgNPs are produced
using fungal cultures able to bioaccumulate metals and
synthesize NPs, which are excreted outside cells using
their ﬁlaments (Srivastava and Mukhopadhyay, 2015).
Some commonly used fungi for AgNP production are
Verticillium (Mukherjee et al., 2001), Aspergillus ﬂavus
(Vigneshwaran et al., 2007) and Fusarium oxysporum
(Ahmad et al., 2003). AgNP synthesis using bacterial
cell extracts from Lactobacillus acidophilus (Rajesh
et al., 2015) or Corynebacterium glutamicum (Gow-
ramma et al., 2015) has also been investigated.
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Recently, selenium NPs (SeNPs) has emerged as a
new class of potential antimicrobial agents. Selenium is
an essential micronutrient in biologic systems; it has
anticancer and antimicrobial properties, antioxidant
effects and modulation functions for the immune system
(Sadeghian et al., 2012). Despite these roles, selenium
can be found in the environment as toxic forms, such as
selenate (SeO4
2), selenite (SeO3
2) and selenide
(Se2) (Lampis et al., 2014). Toxicity of these selenium
anions depends on their mobilization and availability in
soils and water, improving the possibility of exposure for
humans and animals (Lampis et al., 2014). In this
respect, efforts have been made to identify a non-toxic
form of selenium useable in biomedical applications
(Wang et al., 2013). Recently, it has been established
that SeNPs have higher biocompatibility and lower toxic-
ity in humans compared with bulk selenium (Lampis
et al., 2014). Additionally, SeNPs have unique physical
and chemical properties due to their large surface–vol-
ume ratio, large surface energy, spatial conﬁnement and
reduced imperfections (Stroyuk et al., 2008). In this
regard, SeNPs possess adsorptive ability, oxidation func-
tions and marked biological reactivity, including antihy-
droxyl radical efﬁcacy (Lampis et al., 2014). SeNPs are
normally synthesized by chemical reduction of selenite
or selenous acid by reducing agents such as glutathione
(GSH), hydrazine, sodium borohydride (NaBH4), stan-
nous chloride SnCl2, L-cysteine, ascorbic acid, sodium
thiosulfate (Na2S2O3) and SDS (Stroyuk et al., 2008).
These techniques are unfavourable as they produce par-
ticles that are subject to photocorrosion (Dobias et al.,
2011). Yet, it is now possible to produce SeNPs of vari-
ous compositions, sizes and morphologies using bacteria
(Lampis et al., 2014). A number of bacterial species,
residing in diverse terrestrial and aquatic environments,
are resistant to selenium oxyanions and possess the
ability to reduce selenite and selenate into its less
bioavailable elemental form (Se0; Stolz et al., 2006).
This process occurs through both enzymatic and non-
enzymatic mechanisms, leading to the formation of
SeNPs that are deposited inside the cell periplasm or
excreted (Kessi et al., 1999; Oremland et al., 2004;
Dhanjal and Cameotra, 2010).
One of the most clinically sought properties of SeNPs
is their ability to inhibit pathogenic bioﬁlm formation
(Wang and Webster, 2012). Most bacteria have the
innate ability to populate, as a bioﬁlm, a vast array of
surfaces, including those where sterility is of paramount
importance to human health, as food-processing facili-
ties, dental hygiene equipment and medical devices to
name a few (Harrison et al., 2004). Two of the most dif-
fuse and harmful bacteria able to grow as bioﬁlms
responsible for human pathogenic infections are Staphy-
lococcus aureus, which is a Gram-positive bacterium
that causes many serious infections in surgical wounds,
bloodstream or in the lungs (Alhede et al.,2009), and
Pseudomonas aeruginosa, which is a Gram-negative
bacteria recognized as one of the most important noso-
comial opportunistic pathogens, affecting the urinary
tract, respiratory system, soft tissue, bone and joint tis-
sue (Alhede et al., 2009). Of particular interest here are
bioﬁlms of these species, which are able to grow on arti-
ﬁcial orthopaedic implants made of hydroxyapatite (HA)
– causing severe infections (Kolmas et al., 2015a). HA
is a naturally occurring mineral formed by calcium and
phosphate ions – Ca5(PO4)3(OH) – with a recognizable
crystalline structure (Elliot, 1994). HA is also the princi-
pal component of bones and teeth in humans and ani-
mals and is therefore used regularly in orthopaedic
surgery and for the replacement of teeth (Gong et al.,
2015). To prevent bacterial contamination and subse-
quent infection, research efforts have focused on devel-
oping medical devices and implants out of materials
modiﬁed with antimicrobial agents such as antibiotics or
metallic compounds that are able to kill bacterial cells,
or inhibit their growth, without being in general toxic to
surrounding tissues (Kolmas et al., 2015a; Lim et al.,
2013; Harrison et al., 2004). However, with the broad
use and abuse of antibiotics, the emergence of bacte-
rial resistance to these antimicrobials has become one
of the greatest health challenges worldwide. Moreover,
the use of metallic compounds as coating can cause
severe problems, such as ion release in human body
and development of several side-effects (Crobb and
Schmalzereid, 2006). Indeed, some metal ions can
undergo corrosion processes, activating immunological
responses and cytotoxic and genotoxic effects (Jacobs
et al., 1994; Merritt and Rodrigo, 1996). Furthermore,
the ionic species present in HA are normally subject to
substitution processes that can dramatically change the
structure and properties of HA itself (Kolmas et al.,
2015b).
Recently, to overcome both bacterial resistance to
antibiotics and the side-effects of metallic compounds,
new antimicrobial technologies for HA-based implants
have been investigated, such as the use of nano-sized
HA conjugated with chemical NPs known for their
antimicrobial ability (Kolmas et al., 2015b). In this
regard, due to the peculiar chemistry of nanomaterials
as compared to one of the bulk ions, the use of NPs
as antimicrobial agents could constitute an alternative
choice to the use of metallic ions. Speciﬁcally, chemi-
cally synthesized SeNPs were already evaluated as
possible doping for HA-based implants, thanks to either
their antimicrobial or anticancer properties (Kolmas
et al., 2015b; Wang et al., 2016). Selenium also plays
a crucial role in bone growth and proliferation of osteo-
blasts (Kolmas et al., 2015b), and SeNPs could prove
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to be an added value as an antimicrobial coating for
HA-based implants.
In this study, we evaluated the antimicrobial and anti-
bioﬁlm efﬁcacy of biogenic SeNPs as a useful and alterna-
tive approach to chemically synthesized SeNPs, which
are already described for their ability to inhibit bioﬁlm pro-
liferation (Wang and Webster, 2012). The antimicrobial
properties of both chemical and our biogenic Se-nanoma-
terials were studied towards P. aeruginosa and S. aureus
bioﬁlms grown onto HA-coated surfaces. Biogenic SeNPs
were produced by exposing Bacillus mycoides SelTE01
for either 6 or 24 h to Na2SeO3. This strain is a Gram-
positive bacterium isolated from the selenium hyperaccu-
mulator plant Astragalus bisulcatus described for its ability
to reduce selenite oxyanion into its elemental form as
SeNPs (Lampis et al., 2014). Chemical SeNPs were syn-
thesized using L-cysteine (Li et al., 2010) or ascorbic acid
(Zhang et al., 2004) as reducing agents.
Results
Characterization of SeNPs
The hydrodynamic diameter of chemically and biogeni-
cally produced SeNPs has been evaluated by dynamic
light scattering (DLS) analysis (Fig. 1). Biogenic SeNPs
produced by B. mycoides SelTE01 after 6 h of
Na2SeO3 exposure are characterized by a sharp peak
at 160  58.6 nm (Fig. 1A), while a broad and shifted
peak of 209.1  79.1 nm has been detected for those
obtained after 24 h of growth in the presence of the
selenite precursor (Fig. 1B). DLS number size distribu-
tions of SeNPs produced using L-cysteine (L-cys
SeNPs) or ascorbic acid (Asc SeNPs) show sharp and
deﬁned peaks at 99.8  30.2 nm and 170.5  64.4 nm
respectively (Fig. 1C and D). Furthermore, polydisper-
sity indexes (PDIs) of both chemically and biogenically
synthesized SeNPs have been also evaluated to study
the stability of NPs in solution. L-cys SeNPs and bio-
genic SeNPs produced after 6 h of Na2SeO3 exposure
are characterized by similar PDI values, namely 0.198
and 0.220. Moreover, comparable PDI values for Asc
SeNPs (0.312) and those biogenically synthesized after
24 h of precursor exposure (0.290) have been deter-
mined.
Transmission Electron Microscopy (TEM) micrographs
of biogenically produced SeNPs highlighted the pres-
ence of spherical highly electron-dense NPs different in
size and embedded in a light grey and uniform matrix
(Fig. 2A and B). Analysis of L-cys SeNPs showed spher-
ical and strongly electron-dense NPs more uniform in
size rather than those biogenically produced (Fig. 2C).
Considering Asc SeNPs, TEM image showed big NPs
with aggregates in the population (Fig. 2D). However, in
both chemical SeNP classes, the presence of an embed-
ding matrix has not been detected.
Elemental composition of biogenically and chemically
produced SeNPs has been evaluated by performing
energy-dispersive X-ray spectroscopy (EDX). Biogenic
SeNPs produced by B. mycoides SelTE01 after 6 or
24 h of Na2SeO3 exposure revealed the presence of
the characteristic Se absorption peaks at 1.37 (SeLa),
11.22 (SeKa) and 12.49 (SeKb) keV, while only the
SeLa peak was detected in both chemically synthesized
SeNPs (Fig. 3). Moreover, both biogenic and chemical
SeNPs showed similar elemental composition, with the
presence of selenium, carbon, oxygen, phosphorus and
sulphur, but in different relative percentages (Table 1).
Biogenically synthesized SeNPs showed minor
Fig. 1. Dynamic light scattering (DLS) analysis of biogenic SeNPs produced by Bacillus mycoides SelTE01 after 6 (A) or 24 h (B) of Na2SeO3
exposure, and chemical SeNPs made using L-cysteine (C) or ascorbic Acid (D).
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differences in the detected relative percentage values
of P and S, while C, O and Se were present in similar
amount in both samples. Overall, the relative percent-
age values of carbon, oxygen, phosphorous and sul-
phur for biogenic SeNPs suggested the presence of
organic molecules associated with the extracted
SeNPs, and TEM observations conﬁrmed the presence
of a slightly electron-dense material surrounding the
particles. Thus, from here on, we refer to biogenically
synthesized SeNPs as Spherical Bio Se-Nanostructures
Embedded in an Organic material (Bio Se-NEMO-S).
Particularly, Bio Se-NEMO-S6 and Bio Se-NEMO-S24
refer to the biogenic SeNPs produced by B. mycoides
SelTE01 after 6 and 24 h of Na2SeO3 exposure
respectively.
For both chemically synthesized SeNPs, the same ele-
ments (C, O, Se, P, S) are present yet with different rela-
tive percentage values, due to the procedure of the
production, using either L-cysteine or ascorbic acid as
reducing agent (Table 1).
Zeta potential measurements have been carried out to
study the stability of either Bio Se-NEMO-S or chemical
SeNPs in solution. In all four cases, a highly negative
zeta potential value has been detected (Fig. 4). Particu-
larly, both Bio Se-NEMO-S6 and Bio Se-NEMO-S24 gen-
erated the same surface charge of 74.2 mV (Fig. 4A
and B), while L-cys and Asc SeNPs showed a Z
potential value of 67.9 and 75.9 mV respectively
(Fig. 4C and D).
Evaluation of the antimicrobial ability of Bio Se-NEMO
and chemical SeNPs
Antimicrobial activity against established
bioﬁlms. Eradication of an established bioﬁlm has been
evaluated growing both P. aeruginosa NCTC 12934
(Figs 5A and 6A) and S. aureus ATCC 25923 (Figs 5B
and 6B) strains for 24 h prior the treatment with each
tested Se-nanomaterial using HA-coated Calgary Bioﬁlm
Devices (CBDs) to allow the growth of bioﬁlms (Harrison
et al., 2010). Results are shown for both Bio Se-NEMO-S
(Bio Se-NEMO-S6 and Bio Se-NEMO-S24) and chemical
SeNPs (L-cys and Asc SeNPs). Particularly, in the case of
P. aeruginosa grown bioﬁlm, Bio Se-NEMO24 and Asc
SeNPs showed a 2 log decrease in the cell viable count at
the concentration of 2.5 mg ml1, while a slight
antimicrobial activity (1 log reduction) has been observed
for Bio Se-NEMO-S6 and L-cys SeNPs (Figs 5A and 6A).
Considering S. aureus established bioﬁlm, Bio Se-NEMO-
S24 and Bio Se-NEMO-S6 affected its ﬁtness with a 2 log
reduction in the cellular population at the concentrations
of 0.625 and 1.25 mg ml1 respectively (Figs 5B and 6B).
Moreover, Bio Se-NEMO-S24 exerted their strongest
antimicrobial ability (4 log) against S. aureus grown
(A) (B)
(C) (D)
Fig. 2. Transmission Electron Microscopy (TEM) analysis of biogenic SeNPs produced by Bacillus mycoides SelTE01 after 6 (A) or 24 h (B) of
Na2SeO3 exposure, and chemical SeNPs made using L-cysteine (C) or ascorbic Acid (D).
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bioﬁlm at 2.5 mg ml1, while the same concentration of L-
cys and Asc SeNPs determined a 2 log decrease upon
the cells within the bioﬁlm (Figs 5B and 6B).
Nevertheless, in the range of tested concentrations, none
of the studied Bio Se-NEMO-S or SeNPs classes showed
a complete eradication of a pre-formed bioﬁlm. Thus, a
Minimal Bioﬁlm Eradication Concentration (MBEC), that is
the concentration of either Bio Se-NEMO-S or chemical
SeNPs at which there is the eradication of an already
established bioﬁlm, could not be determined.
Table 1. Elemental quantiﬁcation (as weight relative percentage) of Bio Se-NEMO and chemical SeNPs.
Bio Se-NEMO-S Chemical SeNPs
Bio Se-NEMO-S6 Bio Se-NEMO-S24 L-cys SeNPs Asc SeNPs
Element Weight (Rel. %) Weight (Rel. %) Weight (Rel. %) Weight (Rel. %)
Selenium (Se) 9.26 9.82 31.61 16.04
Carbon (C) 75.75 80.71 60.91 76.88
Oxygen (O) 10.82 8.45 4.97 6.27
Phosphorous (P) 3.14 0.73 1.88 0.62
Sulphur (S) 1.04 0.29 0.63 0.19
Elemental quantiﬁcation is expressed as weight relative percentage of the element detected in the SeNPs samples.
Fig. 3. Energy-dispersive X-ray spectroscopy (EDX) spectra of Bio Se-NEMO-S produced by Bacillus mycoides SelTE01 after 6 (A) or 24 h (B)
of Na2SeO3 exposure, and chemical SeNPs made using L-cysteine (C) or ascorbic Acid (D).
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Inhibition of bioﬁlm formation and growth. The CBDs
were also used to evaluate the potential of either Bio
Se-NEMO-S or SeNPs to inhibit bioﬁlm formation by
adding Se-nanomaterials at the time of inoculation. In
this assay, the bacterial cells must survive the stress/
challenge of the biocide (Bio Se-NEMO-S or SeNPs) in
the planktonic state long enough to initiate attachment
and then proliferate as a bioﬁlm. The data are plotted as
number of P. aeruginosa (Figs 7A and 8A) or S. aureus
(Figs 7B and 8B) viable cells (24 h) at varying
concentrations of biocide.
For either Bio Se-NEMO-S or chemical SeNPs that
demonstrated high antimicrobial activity, a Minimal Bio-
ﬁlm Prevention Concentration (MBPC), deﬁned as the
concentration after which an antimicrobial agent is able
to totally inhibit and prevent cell attachment and bioﬁlm
proliferation, was established. Using this approach, an
antibioﬁlm efﬁcacy with differences in trends between
chemical SeNPs and Bio Se-NEMO-S has been
observed. Both Bio Se-NEMO-S6 and Bio Se-NEMO-S24
showed very good antimicrobial activity with deﬁned
MBPC that totally inhibited the establishment and growth
of P. aeruginosa and S. aureus bioﬁlms. In particular,
Bio Se-NEMO-S6 has strong antibioﬁlm efﬁcacy as well
as Bio Se-NEMO-S24 against both tested strains, with
MBPC values of 0.078 and 0.3125 mg ml1 respectively
(Fig. 7A and B). These results also showed that both L-
cys and Asc SeNPs are not able to completely prevent
the formation of the pathogen indicator strain bioﬁlms
(Fig. 8A and B). However, L-cys SeNPs still maintained
antibioﬁlm activity, as they caused a decrease in the
number of P. aeruginosa (3 log) and S. aureus (4 log)
viable cells. Finally, Asc SeNPs showed a slight antimi-
crobial ability for the two tested strains. In particular, we
Fig. 4. Zeta potential measurements of Bio Se-NEMO-S produced by Bacillus mycoides SelTE01 after 6 (A) or 24 h (B) of Na2SeO3 exposure,
and chemical SeNPs made using L-cysteine (C) or ascorbic acid (D).
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observed a 1 log reduction in the number of bioﬁlm-resi-
dent bacteria against P. aeruginosa and 2 log in the
case of S. aureus. As chemically synthesized SeNPs
show a moderate antimicrobial ability, MBPC values
were determined only for Bio Se-NEMO-S.
Efﬁcacy on planktonic cultures. Efﬁcacy of the both Bio
Se-NEMO-S and chemical SeNPs against planktonic cells
of P. aeruginosa (Figs 9A and 10A) and S. aureus
(Figs 9B and 10B) was also tested. Results demonstrated
a strong antimicrobial effect of Bio Se-NEMO-S on
planktonic cultures of the tested strains. In this case, a
Minimal Inhibitory Concentration (MIC), that is the
concentration of an antimicrobial agent after which there is
no planktonic cells growth, has been established for Bio
Se-NEMO-S. Particularly, the MIC values of Bio Se-
NEMO-S were equal to the MBPC values established for
inhibiting bioﬁlm growth, being 0.078 mg ml1 for Bio Se-
NEMO-S6 and 0.3125 mg ml
1 for Bio Se-NEMO-S24
against both P. aeruginosa and S. aureus cultures (Fig. 9A
and B). Among the chemically synthesized SeNPs, L-cys
SeNPs reveal a moderate antimicrobial activity at the
highest tested concentrations (1.25–2.5 mg ml1) with a 4
log decrease in the number of P. aeruginosa and
S. aureus growing cells (Fig. 10A and B). Moreover, Asc
Fig. 5. Minimal Bioﬁlm Eradication Concentration (MBEC) assays of
Pseudomonas aeruginosa NCTC 12934 (A) and Staphylococcus
aureus ACTT 25923 (B) established bioﬁlms for 24 h, and subse-
quently exposed for 24 h to Bio Se-NEMO-S6 and Bio Se-
NEMO-S24. Error bars show the standard deviation.
Fig. 6. Minimal Bioﬁlm Eradication Concentration (MBEC) assays of
Pseudomonas aeruginosa NCTC 12934 (A) and Staphylococcus
aureus ACTT 25923 (B) established bioﬁlms for 24 h, and subse-
quently exposed for 24 h to L-cys SeNPs and Asc SeNPs.
Error bars show the standard deviation.
Fig. 7. Minimal Bioﬁlm Prevention Concentration (MBPC) assays of
Pseudomonas aeruginosa NCTC 12934 (A) and Staphylococcus
aureus ACTT 25923 (B) growing bioﬁlms exposed for 24 h to
Bio Se-NEMO-S6 and Bio Se-NEMO-S24. Error bars show the
standard deviation.
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SeNPs display a slight efﬁcacy only against S. aureus
planktonic population (2 log reduction), without any
decrease in the number of P. aeruginosa cells (Fig. 10A
and B). Due to their moderate antimicrobial efﬁcacy, no
MIC values have been established for chemical SeNPs.
Confocal Laser Scanning Microscopy (CLSM) analysis
P. aeruginosa (Fig. 11) and S. aureus (Fig. 12) bioﬁlms
growing on HA-coated pegs in the presence of either Bio
Se-NEMO-S or chemical SeNPs have been observed by
performing CLSM analyses. We chose to analyse Bio
Se-NEMO-S6, as this nanomaterial possessed the stron-
gest antibioﬁlm activity, making a comparison with L-cys
SeNPs, which showed the highest antimicrobial efﬁcacy
among the tested chemical SeNPs. Speciﬁcally, we anal-
ysed three samples of P. aeruginosa and S. aureus
growing bioﬁlms exposed to the different Bio Se-NEMO-
S6 SeNP concentrations of 0.039, 0.078 mg ml
1 (estab-
lished MBPC) and 1.25 mg ml1. Due to the absence of
an deﬁned MBPC for L-cys SeNPs, the antimicrobial
effect of these NPs has been evaluated exposing
P. aeruginosa and S. aureus growing bioﬁlms to the
three highest SeNP concentrations of the tested range:
0.625, 1.25 and 2.5 mg ml1. Samples were stained
using Live/Dead BacLightTM staining kit, as described in
Fig. 8. Minimal Bioﬁlm Prevention Concentration (MBPC) assays of
Pseudomonas aeruginosa NCTC 12934 (A) and Staphylococcus
aureus ACTT 25923 (B) growing bioﬁlms exposed for 24 h to
L-cys SeNPs and Asc SeNPs. Error bars show the standard
deviation.
Fig. 9. Minimal Inhibition Concentration (MIC) assays of Pseu-
domonas aeruginosa NCTC 12934 (A) and Staphylococcus aureus
ACTT 25923 (B) growing planktonic cells exposed for 24 h to
Bio Se-NEMO-S6 and Bio Se-NEMO-S24. Error bars show the
standard deviation.
Fig. 10. Minimal Inhibition Concentration (MIC) assays of Pseu-
domonas aeruginosa NCTC 12934 (A) and Staphylococcus aureus
ACTT 25923 (B) growing planktonic cells exposed for 24 h to
L-cys SeNPs and Asc SeNPs. Error bars show the standard
deviation.
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the Methods section. Due to the ion exchange chemistry
of HA, the cations of the stain were able to bind to HA,
resulting in a dark green or red background noise
(Figs 11A and 12A), which was different from the brilliant
and strong ﬂuorescence corresponding to the stained
cells.
P. aeruginosa bioﬁlms grown in the presence of the
lowest concentrations of Bio Se-NEMO-S6
(0.039 mg ml1) or L-cys SeNPs (0.625 mg ml1;
Fig. 11C and F) were characterized by a strong green-
ﬂuorescent signal, indicating a mature and vibrant bio-
ﬁlm. However, P. aeruginosa bioﬁlm exposed to the
(A)
(B)
(C) (D) (E)
(F) (G) (H)
Fig. 11. Confocal Laser Scanning Microscopy (CLSM) of HA-coated peg (A), Pseudomonas aeruginosa bioﬁlm grown onto HA-coated peg (B)
and in the presence of bio6 SeNPs at the concentration of 0.039 mg ml1 (C), 0.078 mg ml1 (MBBC) (D), 1.25 mg ml1 (E), or in the pres-
ence of L-cys SeNPs at the concentration of 0.625 mg ml1 (F), 1.25 mg ml1 (G), 2.5 mg ml1 (H).
(A)
(B)
(C)
(F)
(D)
(G)
(E)
(H)
Fig. 12. Confocal Laser Scanning Microscopy (CLSM) of HA-coated peg (A), Staphylococcus aureus bioﬁlm grown onto HA-coated peg (B)
and in the presence of bio6 SeNPs at the concentration of 0.039 mg ml1 (C), 0.078 mg ml1 (MBBC) (D), 1.25 mg ml1 (E), or in the pres-
ence of L-cys SeNPs at the concentration of 0.625 mg ml1 (F), 1.25 mg ml1 (G), 2.5 mg ml1 (H).
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action of Bio Se-NEMO-S6 showed a reduced consis-
tency (375 lm), while L-cys SeNPs had a slight effect
on bioﬁlm thickness (415 lm), being comparable to the
non-treated one (450 lm; Fig. 11B). Observations are
drastically different considering P. aeruginosa bioﬁlms
grown in the presence of 0.078 mg ml1 (MPBC) or
1.25 mg ml1 of Bio Se-NEMO-S6 (Fig. 11D and G),
which showed strong and brilliant red colour, indicating
not viable cells. Moreover, the thickness of these bio-
ﬁlms dropped to values of 150.4 lm for 0.078 mg ml1
or 75.3 lm in the case of the highest tested concentra-
tion (1.25 mg ml1). By contrast, samples grown with
1.25 mg ml1 or 2.5 mg ml1 L-cys SeNPs had both
green- and red-ﬂuorescent signals (Fig. 11E and H),
demonstrating that there was a coexistence of live and
dead bacterial cells. Furthermore, analysis of these sam-
ples showed the presence of thick bioﬁlms for both
tested concentrations of chemical SeNPs, being 223 lm
(1.25 mg ml1) and 185,5 lm (2.5 mg ml1).
S. aureus bioﬁlm grown on HA-coated peg (Fig. 12B)
appeared to be thinner (285 lm) as compared with that
of P. aeruginosa (450 lm). A slight ﬂuorescent signal
was observed when S. aureus cells growing as a bioﬁlm
were exposed to 0.039 or 0.078 mg ml1 (MPBC) of Bio
Se-NEMO-S6 (Fig. 12C and D), resulting in an evaluated
thickness of 94.2 and 2.5 lm respectively. This value
decreased till 0.95 lm when S. aureus bioﬁlm was
grown in the presence of 1.25 mg ml1 of Bio Se-
NEMO-S6, with a ﬂuorescence emission comparable to
the HA-coated peg itself (Fig. 12A and E). On the oppo-
site, the lowest concentration of L-cys SeNPs
(0.625 mg ml1) slightly affected S. aureus bioﬁlm
growth, as highlighted by the strong and green ﬂuores-
cence due to the presence of a live and thicker bioﬁlm
(192.7 lm; Fig. 12F). Moreover, when S. aureus cells
were incubated with 1.25 or 2.5 mg ml1 of L-cys
SeNPs, the growing bioﬁlm displayed a thickness of 114
or 25 lm respectively.
Discussion
In this study, we analyse the potential of either biogenic
SeNPs produced by B. mycoides SelTE01 (Lampis
et al., 2014) indicated as Bio Se-NEMO-S or chemically
synthesized SeNPs (L-cys SeNPs and Asc SeNPs) as
antimicrobial agents against pathogenic indicator strains
P. aeruginosa NCTC 12934 and S. aureus ATCC 25923
grown on CBDs coated with HA, which is an important
bioactive ceramic material used in orthopaedic and den-
tal surgery (Gong et al., 2015). Considering the possible
medical application of such nanomaterials, the toxicity of
either Bio Se-NEMO-S produced by B. mycoides
SelTE01 or chemical SeNPs towards human cells has
been investigated by Cremonini et al. (2016), showing
no cytotoxicity and biocompatibility with human cell lines
(i.e. dendritic cells and ﬁbroblasts).
In the evaluation of Se-nanomaterials’ ability to eradi-
cate both established P. aeruginosa and S. aureus bio-
ﬁlms, either Bio Se-NEMO-S or chemical SeNPs led to a
decrease in the number of viable cells. Bio Se-NEMO-
S24 SeNPs showed the strongest antimicrobial activity at
concentration ranging from 0.625 to 2.5 mg ml1 against
S. aureus grown bioﬁlm. In this respect, the moderate
efﬁcacy of antimicrobials towards an already established
bioﬁlm is due to the complexity of the bioﬁlm structure
itself. In particular, bacterial cells within a bioﬁlm are sur-
rounded by an extracellular polymeric substance (EPS),
which provides structural stability, as well as acts like a
barrier against antibiotics, metallic ions and bactericides
(Harrison et al., 2004). Moreover, a subpopulation of bio-
ﬁlm-resident bacteria behaves as persister cells, which
are dormant and metabolically inactive (Hobby et al.,
1942). These cells were observed for the ﬁrst time by
Hobby et al. (1942) and Bigger (1944) studying the
effect of penicillin against S. aureus and S. pyogenes
strains respectively. In both cases, some cells were able
to survive in the presence of the antibiotic without under-
going genetic change. In this regard, persister cells
should be considered as a subpopulation of bacteria with
tolerance to antibiotics (Bigger, 1944). The presence of
both EPS and persister cells inside a bioﬁlm structure
can explain the modest antimicrobial activity of tested
Se-nanomaterials in the eradication of P. aeruginosa
and S. aureus established bioﬁlms.
In the present study, the antimicrobial efﬁcacy of Bio
Se-NEMO-S and chemically synthesized SeNPs has
been also evaluated towards P. aeruginosa and S. au-
reus cells growing under either planktonic or bioﬁlm con-
ditions. In both scenarios, Bio Se-NEMO-S highlighted a
great and equivalent antimicrobial ability against the
tested strains. Particularly, growth of planktonic cells and
bioﬁlm formation are inhibited at the same concentra-
tions of Bio Se-NEMO-S6 (0.078 mg ml
1) and Bio Se-
NEMO24 (0.3125 mg ml
1) for both P. aeruginosa and
S. aureus strains respectively. Notably, Bio Se-NEMO-
S6 were more efﬁcient than Bio Se-NEMO-S24 in pre-
venting the bioﬁlm establishment and growth. Zonaro
et al. (2015) have observed a similar behaviour for
SeNPs produced by Stenotrophomonas maltophilia
SelTE02, when it was exposed to Na2SeO3 for 6 or
24 h. In this case, those produced after 6 h showed a
stronger antimicrobial activity against P. aeruginosa
PAO1, S. aureus ATCC 25923 and E. coli JM109 strains
rather than those obtained after 24 h (Zonaro et al.,
2015). This diversity in action for biogenic SeNPs is
ascribed to the different size of SeNPs themselves
(Zonaro et al., 2015). Similar results have been
observed by Lu et al. (2013) in the evaluation of AgNPs’
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action as antimicrobial agents against oral anaerobic
pathogenic bacteria. Lu et al. (2013) indicated a size-
dependent mechanism of AgNPs’ action, by which smal-
ler NPs have higher antimicrobial effect. In our study,
the same observation is supported by DLS analyses, in
which Bio Se-NEMO-S6 showed a smaller hydrodynamic
diameter (160 nm) as compared to Bio Se-NEMO-S24
(209.1 nm). Furthermore, the Bio Se-NEMO-S sizes sug-
gested the existence of a time-dependent mechanism of
biogenic SeNPs’ production. In this regard, improving the
exposure time of B. mycoides SelTE01 to the selenium
precursor (Na2SeO3) resulted in the production of bigger
Se-nanomaterials, as already described by Lampis et al.
(2014). As Bio Se-NEMO-S6 showed the highest antimi-
crobial ability among all tested NPs, we further performed
CLSM analyses to evaluate the ﬁtness of P. aeruginosa
and S. aureus cells growing as a bioﬁlm in the presence
of this class of biogenic SeNPs. As we observed a reduc-
tion in the thickness of both studied bioﬁlms, CLSM
observations correlate with our kill curve results. Never-
theless, P. aeruginosa and S. aureus growing bioﬁlms
showed completely different ﬂuorescence emission at the
efﬁcient concentration of Bio Se-NEMO-S6, resulting in a
strong red-ﬂuorescent signal or in one comparable to the
HA-coated peg control respectively.
These data suggest two possible distinct modes of
antimicrobial action of Bio Se-NEMO-S6 depending on
the pathogenic indicator strain analysed. The presence
of large amount of red cells in P. aeruginosa bioﬁlm
underlines Bio Se-NEMO6 ability to kill bacterial cells or
to limit the number of viable cells. At the same time, the
absence of thick S. aureus bioﬁlm highlights Bio Se-
NEMO-S6 action in inhibiting irreversible attachment of
bacterial cells to form a bioﬁlm.
Chemically synthesized SeNPs showed less antimicro-
bial activity towards both P. aeruginosa and S. aureus
planktonic cell growth and bioﬁlm formation compared to
those biogenically produced. Tran and Webster (2011)
observed similar results in the evaluation of the antimi-
crobial efﬁcacy of chemical SeNPs against planktonic
cells of S. aureus. CLSM observations of both P. aerugi-
nosa and S. aureus growing bioﬁlms in the presence of
L-cys SeNPs conﬁrm our kill curve results. Even at the
highest L-cys SeNPs tested concentration, P. aerugi-
nosa cells exhibited a green-ﬂuorescence emission, indi-
cating the presence of live cells in the bioﬁlm. Moreover,
an established and thick bioﬁlm was observed in the
case of S. aureus cells incubated in the presence of
1.25 mg ml1 L-cys SeNPs, while a slight inhibition is
revealed at the highest tested concentration
(2.5 mg ml1).
The higher antimicrobial ability of Bio Se-NEMO-s as
compared to those chemically synthesized could be
explained by the presence of an embedding organic
matrix that surrounded these nanomaterials, as con-
ﬁrmed by TEM analyses, EDX spectra and zeta poten-
tial measurements. Speciﬁcally, L-cys and Asc SeNPs
TEM images underlined evidence of SeNPs in a bright
and white ﬁeld, while both Bio Se-NEMO-S were char-
acterized by a grey slightly electron-dense surrounding
material. EDX analyses of all Se-nanomaterials high-
lighted the presence of carbon, oxygen, phosphorous
and sulphur, along with selenium. Considering the syn-
thesis procedure of chemical SeNPs, the detection of
these elements in EDX analyses is explained by the
use of either L-cysteine, rich in C, O and S, or ascorbic
acid, rich in C and O, for the production (Zhang et al.,
2004; Li et al., 2010). In the case of Bio Se-NEMO-S,
the existence of C, O, P and S suggested the evidence
of selenium nanoparticles surrounded by an organic
material. These observations were validated by zeta
potential measurements, in which both Bio Se-NEMO-S
and chemical SeNPs showed strongly negative surface
charge values. Considering that elemental selenium
(Se0) does not have a net charge, these results sug-
gested that the stability of the Se-nanomaterials in solu-
tion is facilitated by the presence of negatively charged
organic chemical groups. The association of SeNPs
produced by B. mycoides SelTE01 with a surrounding
material has been observed also by Lampis et al.
(2014), which ascribed the nature of this external layer
to the adhesion of proteins to SeNPs. The existence of
proteins associated with biogenic SeNPs has been
established and studied for other bacterial strains able
to reduce selenium oxyanions to elemental selenium
(Se0). Debieux et al. (2011) have identiﬁed some pro-
teins associated with SeNPs produced by Thauera sele-
natis that played an important role in stabilizing the
formation of NPs, while Lenz et al. (2011) highlighted
that SeNPs produced by Bacillus selenatarsenatis and
Sulfurospirillum barnesii were characterized by the
association with several high-afﬁnity proteins. Recently,
Zonaro et al. (2015) have observed the presence of
several organic compounds surrounding biogenic
SeNPs produced by S. maltophilia SelTE02, which have
been characterized as carbohydrates, lipids and pro-
teins by Lampis et al. (2016) using FT-IR analyses. This
evidence complements our characterization analyses
regarding the presence of associated organic material
surrounding biogenic SeNPs.
In our study, despite DLS results that showed a
deﬁned size for all the studied Se-nanomaterials, TEM
analyses highlighted the presence of smaller yet
monodispersed SeNPs in Bio Se-NEMO-S samples of
less than 100 nm in size. Probably, this discrepancy in
size between DLS measurements and TEM observations
is due to the contribution of the organic surrounding
material in which biogenic SeNPs are embedded.
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Conclusions
In our study, we evaluated the antimicrobial efﬁcacy of
biogenic SeNPs produced by B. mycoides SelTE01 (Bio
Se-NEMO-S) compared to chemical SeNPs against two
pathogenic indicator strains, P. aeruginosa NCTC 12934
and S. aureus ATCC 25923, grown onto HA-coated
pegs. Bio Se-NEMO-S showed higher antimicrobial efﬁ-
cacy as compared to chemically synthesized SeNPs in
all three evaluated scenarios for both tested strains. Dif-
ference in antimicrobial ability of these Se-nanomaterials
suggests either distinct chemistry or the involvement of
the organic surrounding material associated with the
SeNPs (Bio Se-NEMO-S) originating from Bacillus
mycoides SelTE01. Finally, this study demonstrates
good promise of utilizing Bio Se-NEMO-S as antimicro-
bial agents to inhibit bioﬁlm formation onto HA-coated
pegs.
Experimental procedures
Materials, media and organisms used
Bacillus mycoides SelTE01 has been isolated previously
from the rhizosphere of the Se-hyperaccumulating plant
Astragalus bisulcatus (Lampis et al., 2014). The two
deﬁned indicator strains used are P. aeruginosa NCTC
12934 and S. aureus ATCC 25923. Nutrient broth, agar
and sodium chloride (NaCl) were obtained from Oxoid,
Basingstoke Hampshire, England. Sodium selenite
(Na2SeO3), octanol, L-cysteine, ascorbic acid, L-histi-
dine, reduced glutathione were obtained from Sigma
Aldrich, St. Louis, MO, USA. Tris–HCl 1.5 mM was
made by adding 0.091 g of Trizma base (Sigma Aldrich)
to 500 ml of water, and then, using HCl from Sigma
Aldrich, pH was adjusted to 7.0. HA-coated Calgary Bio-
ﬁlm Device (CBD) plates or MBECTMwas obtained from
Innovotech, Edmonton, AB, Canada.
Methods
Chemical synthesis of SeNPs. SeNPs were chemically
synthesized by adding 500 ll of 100 mM Na2SeO3 to
500 ll of 50 mM L-cysteine as the reducing agent and
1 ml of milli-Q water (L-cys SeNPs) (Li et al., 2010), or
using 1 ml of 30 mM ascorbic acid (reducing agent) to
200 ll of 100 mM Na2SeO3 and 800 ll of milli-Q water
(Asc SeNPs; Zhang et al., 2004).
Biogenic SeNPs (Bio Se-NEMO) synthesis. Following
the protocol established by Lampis et al. (2014),
B. mycoides SelTE01 was grown in culture tubes with
4 ml of nutrient broth medium for a minimum 24 h at
130 rpm. These cultures were used to inoculate 1-l
ﬂasks containing 400 ml of nutrient broth medium and
8 ml of ﬁlter sterilized Na2SeO3 (100 mM). The cultures
were subsequently incubated at 27°C at 130 rpm, for
24 h. During this incubation, reduction of SeO3
2 ions to
Se0 was observed visually through the formation of a
red colour solution, typical of colloidal elemental
selenium. Samples were collected after 6 and 24 h.
To extract the Se-nanomaterial from B. mycoides cul-
tures, the contents of each ﬂask were divided into eight
50-ml conical tubes and collected by centrifugation at
10 000 9 g for 10 min. Pellets were washed twice with
0.9% NaCl solution, resuspended in Tris/HCl buffer (pH
8.2) and then disrupted by ultrasonication at 100 W for
5 min. The suspension was then centrifuged at
10 000 9 g for 30 min to separate disrupted cells (pel-
let) from nanomaterials (supernatant), which were recov-
ered after centrifugation at 40 000 9 g for 30 min,
washed twice with saline solution (0.9% NaCl) and
resuspended in deionized water. This washed sus-
pended material is what we characterize here and is
deﬁned as Spherical Bio Se-Nanostructures Embedded
in an Organic material (Bio Se-NEMO-S).
Characterization of Bio Se-NEMO-S and SeNPs. Size,
polydispersity index (PDI) and surface charge of chemical
and biogenic SeNPs (Bio Se-NEMO-S) have been studied
by evaluating their dynamic light scattering (DLS) and
measuring their zeta potential. DLS measurements for
all Se-nanomaterials have been evaluated using Zen
3600 Zetasizer Nano ZS from Malvern Instruments
(Worcestershire, UK) (Cremonini et al., 2016).
Hydrodynamic diameter and PDI values were obtained
using the software provided by the Malvern with the
instrument. All the samples were then transferred to a
quartz cuvette (10 mm path length), and the zeta potential
at pH 7 has been measured at 25°C using the Malvern
software. TEM analyses have been carried out to study
morphology, size and shape for both the chemical and
biogenic (Bio Se-NEMO-S) Se-nanomaterials. For TEM
observations, 5 ll of each Se-nanomaterials was mounted
on carbon-coated copper grids (CF300-CU; Electron
Microscopy Sciences, Hatﬁeld, PA, USA). Then, samples
were air-dried and visualized using a Hitachi H7650 TEM.
Finally, EDX spectra have been performed using an XL30
ESEM (FEI) equipped with an EDX micro-analytical system.
Each sample was ﬁxed, dehydrated through an increasing
ethanol concentration series and dried in liquid CO2. The
Se-nanomaterials were then mounted on metallic stubs and
directly observed to perform EDX analyses.
Measuring the biocidal activity of Bio Se-NEMO-S and
chemical SeNPs. Kill curve assays were performed to
evaluate the antimicrobial activity of either Bio Se-
NEMO-S or chemical SeNPs. Here, we used the
Calgary Bioﬁlm Device (CBD) that is a 96-well microtitre
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plate lid with pegs protruding into the microtitre plate
wells (Ceri et al., 2001). The use of this device to culture
the bacteria permits high-throughput challenging with
chemically synthesized SeNPs and Bio Se-NEMO-S. In
this study, the CBD pegs had been pre-treated with a
HA coating, generating a system relevant to dental and
orthopaedic medicine. The assay was conducted using
P. aeruginosa (NCTC 12934) and S. aureus (ATCC
25923), both established laboratory indicator strains of
pathogens.
The CBD was inoculated with P. aeruginosa or S. au-
reus cells grown in nutrient broth medium along with
solutions of either Bio Se-NEMO-S or chemical SeNPs
at various concentrations. We tested two biogenic Se-
nanomaterials produced by B. mycoides SelTE01 after
6 h (Bio Se-NEMO-S6) and 24 h (Bio Se-NEMO-S24) of
Na2SeO3 exposure. Additionally, we tested two chemi-
cally generated SeNPs made using L-cysteine (L-cys
SeNPs; Li et al., 2010) or ascorbic acid (Asc SeNPs;
Zhang et al., 2004) as reducing agents. Inoculum was
prepared by resuspending biomass collected from a sec-
ond subculture on a nutrient broth–agar plate in sterile
distilled deionized water. Turbidity of the solution was
adjusted to achieve an equivalent optical density of 0.5
McFarland standardized suspension. This suspension
was then diluted in nutrient broth medium to achieve an
approximate cell density of 105 per ml. Overall, we
examined three different scenarios:
i The ability of Bio Se-NEMO-S and SeNPs to eradi-
cate 24-h pre-grown bioﬁlms (minimal bioﬁlm eradica-
tion concentration; MBEC).
ii The ability of Bio Se-NEMO-S and SeNPs to prevent
the formation of a bioﬁlm (minimal bioﬁlm prevention
concentration; MBPC).
iii The ability of Bio Se-NEMO-S and SeNPs to inhibit
planktonic cells growth (minimal inhibitory concentra-
tion; MIC)
For i, the CBD was inoculated with P. aeruginosa or
S. aureus strains at a 0.5 McFarland standard concen-
tration in nutrient broth medium and placed in a gyroro-
tary shaker operating at 150 rpm, 37°C for 24 h.
Following the establishment of a bioﬁlm, solutions con-
taining various concentrations of each tested Se-nano-
materials were added to the wells in twofold serial
dilutions between 2.5 and 0.0025 mg ml1. Experiments
were performed in triplicate. The inoculated CBDs were
placed on a shaker at 150 rpm, 37°C for 24 h.
For ii, CBDs were inoculated with a 0.5 McFarland
standard of the bacterial strains into nutrient broth med-
ium and Bio Se-NEMO-S or chemical SeNPs solutions
were added as described in scenario i, allowing bioﬁlm
growth for 24 h.
To collect bioﬁlm biomass from scenarios i and ii, peg
lids were rinsed twice with 0.9% NaCl to remove loosely
bound cells and then placed into 96-well recovery plates
containing 180 ll each of a mixture 1:100 of universal
neutralizer solution and nutrient broth medium. Finally,
we sonicated for 30 minutes to remove bioﬁlm biomass
from the peg surface.
For iii, 96-well plates containing nutrient medium and
Se-nanomaterial solutions described in scenario i were
inoculated with P. aeruginosa and S. aureus cells. The
inoculated plates were incubated at 37°C with shaking
(150 rpm) for 24 h.
Bioﬁlm and planktonic cells exposed to either Bio Se-
NEMO-S or chemical SeNPs from all three scenarios
were collected and serially diluted into 0.9% saline solu-
tion. Viable cell numbers were determined using spot
plates count. All assays were conducted using three bio-
logical replicates. Data are reported as means with stan-
dard deviations.
Confocal laser scanning microscopy (CLSM). A LEICA
model DM IRE2 microscope was used to collect
confocal images further processed using IMARIS 964
(Bitplane, Concord, MA, USA) software. Brieﬂy,
hydroxyapatite-coated CBD pegs containing bioﬁlms
were aseptically removed from the lid using alcohol-
ﬂamed pliers. The collected pegs were rinsed twice with
200 ll of 0.9% NaCl solution in a microtiter plate and
stained using the Live/Dead BacLightTM stain (Molecular
Probes, Ontario, Canada) for 30 minutes prior to
visualization (Harrison et al., 2006; Cerca et al., 2012).
This kit contains SYTO 9 green-ﬂuorescent nucleic acid
stain and propidium iodide, which is a red-ﬂuorescent
dye (Dailey, 2006). These stains have diverse spectral
characteristics, and they are able to differentially
penetrate bacterial cells. SYTO 9 generally labels all
bacterial cells in population, while propidium iodide
penetrates only bacterial cells with damaged membranes
(Dailey, 2006). The thickness of the bioﬁlms has been
estimated through obtaining high-resolution optical
images with depth selectivity, allowing 3D images of
complex biological samples (Dailey, 2006).
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